Cidara TherapeuticsCDTX
13F holders, Q2 2024 (June 30)25holders
1famous investor
$11.94avg. 13F price*
At the end of Q2 2024, 25 institutions reported holding Cidara Therapeutics Inc. (CDTX) in their 13F filings. The largest holders were Monashee Investment Management LLC ($4.4M), BVF Inc. ($4.1M) and Vanguard Group Inc. ($2.2M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cidara Therapeutics Inc.
- CUSIP
- 171757206
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $1.7M |
| Exits | 0 | $0 |
Ownership 25 holders
| Monashee Investment Management LLC | 0.57% | Add +1900.0% | 369,099 | $4.4M |
| BVF Inc. | 0.11% | No change | 343,055 | $4.1M |
| Vanguard Group Inc. | 0.00% | Add +7.9% | 180,535 | $2.2M |
| Checkpoint Capital L.P. | 1.05% | New | 145,417 | $1.7M |
| Renaissance Technologies | 0.00% | Reduce -25.2% | 95,517 | $1.1M |
| Alethea Capital Management, LLC | 0.72% | No change | 79,908 | $954K |
| 5AM Venture Management, LLC | 0.15% | No change | 56,725 | $677K |
| BlackRock Inc. | 0.00% | Add +35.6% | 48,512 | $579K |
| Geode Capital Management, LLC | 0.00% | Add +2.9% | 43,127 | $515K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -29.7% | 19,400 | $232K |
| State Street Corp. | 0.00% | No change | 13,576 | $162K |
| US Bancorp \de | 0.00% | No change | 13,103 | $156K |
| UBS Group AG | 0.00% | Add +524.9% | 1,467 | $18K |
| Russell Investments Group, Ltd. | 0.00% | No change | 855 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +64.9% | 746 | $9K |
| Manchester Capital Management LLC | 0.00% | New | 470 | $6K |
| Pacifica Partners Inc. | 0.00% | No change | 400 | $5K |
| Morgan Stanley | 0.00% | Reduce -78.3% | 169 | $2K |
| JPMorgan Chase & Co. | 0.00% | Add +370.1% | 106 | $1K |
| Royal Bank of Canada | 0.00% | New | 67 | $1K |
| Allworth Financial LP | 0.00% | No change | 40 | $473 |
| Bank of America Corp. | 0.00% | New | 34 | $406 |
| BNP Paribas Financial Markets | 0.00% | Reduce -3.7% | 17 | $203 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 14 | $167 |
| Qube Research & Technologies Ltd | 0.00% | Reduce -23.1% | 2 | $24 |
"% of holder's portfolio" is CDTX's weight in each manager's 13F, not the share of Cidara Therapeutics Inc. the manager owns.